The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary
Authors:
- 5 October 2010
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 40 (2) , 122-126
Abstract
Objectives: Disproportionate vitamin D levels may play an important role in the development of certain systemic autoimmune and rheumatic diseases. The aim of the present study was to investigate the prevalence of vitamin D insufficiency in patients with systemic lupus erythematosus (SLE) and to compare serological and clinical parameters in patients with different vitamin D levels from a single centre registry in Central-Eastern Europe. Methods: A total of 177 patients with SLE were enrolled in the study. 25-Hydroxyvitamin D [25(OH)D] levels were measured by chemiluminescent immunoassay (CLIA). Autoantibody profiles, complement 3 (C3) and C4, clinical symptoms, and disease activity (using the SLE disease activity index, SLEDAI) of the patients were assessed. Results: Vitamin D concentration in the total SLE group investigated was 26.88 ± 13.25 ng/mL. Vitamin D levels were normal (≥ 30 ng/mL) in 18.1% of patients, insufficient (15–30 ng/mL) in 44.6%, and deficient (< 15 ng/mL) in 37.3%. The vitamin levels were significantly reduced in postmenopausal compared to premenopausal patients (p = 0.02). Patients with pericarditis (p = 0.013), neuropsychiatric diseases (p = 0.01), and deep vein thrombosis (p = 0.014) had reduced vitamin D levels. SLEDAI score was significantly increased in patients with reduced vitamin D levels (p = 0.038). Anti-double-stranded (ds)DNA autoantibody concentrations increased from normal to insufficient and further increased from insufficient to deficient patient subsets (p = 0.021). Anti-Smith antigen (anti-Sm) concentrations increased (p < 0.001), C4 levels decreased (p = 0.027), and immunoglobulin (Ig)G concentration increased (p = 0.034) in patients with reduced vitamin D levels. Conclusions: Our data suggest that vitamin D deficiency in SLE may play a role in perpetuation of the disease.Keywords
This publication has 38 references indexed in Scilit:
- Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosusScandinavian Journal of Rheumatology, 2010
- Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE‐related cardiovascular diseaseScandinavian Journal of Rheumatology, 2009
- Vitamin D deficiency in undifferentiated connective tissue diseaseArthritis Research & Therapy, 2008
- Vitamin D status in gastrointestinal and liver diseaseCurrent Opinion in Gastroenterology, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: A paradigm for ligand-augmented negative transcriptional regulationArchives of Biochemistry and Biophysics, 2007
- Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patientsKidney International, 2001
- High disease activity at baseline does not prevent a remission in patients with systemic lupus erythematosusRheumatology, 1999
- 1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional levelCytokine, 1992
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992